natgillin/translations-raw huggingface dataset:
Dry mouth Faeces hard
uha usta, trdo blato,
Dry mouth Gastritis
neprijeten občutek v
dry mouth headache
uha usta glavobol
dry mouth in combination with thirst and/or reduced or darkened urine,
uha usta v kombinaciji z žejo in/ali manjšim izločanjem seča ali temnejši seč,
dry mouth increased appetite
uha usta; povečan tek.
dry mouth infection of the upper airways.
uha usta, okužba zgornjih dihal.
dry mouth joint pain, aching or tender muscles, not caused by exercise
uha usta bolečina v sklepih, bolečina ali občutljivost v mišicah, ki nista posledica telesne aktivnosti
dry mouth low white blood cell and/or platelet count, decrease in haemoglobin in your blood, increase in triglycerides, lipase and/or bilirubin in your blood
uha usta zmanjšano število belih krvničk in/ali trombocitov, zmanjšana koncentracija hemoglobina v krvi, povečana koncentracija trigliceridov, lipaze in/ali bilirubina v krvi
Dry mouth may be associated with toothache and dental caries; in the subset of patients with dry mouth, a higher incidence of toothache and dental caries were observed in subjects treated with naltrexone / bupropion compared to subjects treated with placebo.
Pojav suhih ust je lahko povezan z zobobolom in zobnim kariesom; v podskupini bolnikov s suhimi usti so pri preiskovancih, zdravljenih z naltreksonom/bupropionom, opazili večjo pojavnost zobobola in zobnega kariesa kot pri preiskovancih, ki so prejemali placebo.
dry mouth or excess saliva
uha usta ali čezmerno izločanje sline
dry mouth or mouth ulcers
uha usta ali razjede v ustih,
Dry mouth Pruritus ani
uha usta, srbenje okoli anusa
Dry mouth Wind
uha usta vetrovi
Dry mouth*, predominantly mild (CTC grade 1).
Suha usta*, pretežno blaga (1. stopnja po CTC)
dry mouth, abdominal pain/discomfort or wind, heartburn/indigestion, constipation, more frequent passing of stools, vomiting, stomach discomfort
uha usta, bolečine/nelagodje v trebuhu ali napenjanje, zgaga/slaba prebava, zaprtost, pogostejše izločanje blata, bruhanje, občutek nelagodja v trebuhu,
dry mouth, alteration of taste
uha usta, sprememba okusa
dry mouth, altered taste (dysgeusia)
uha usta, spremenjen okus (disgevzija)
dry mouth, constipation
uha usta, zaprtost,
dry mouth, constipation, indigestion, loss of appetite
uha usta, zaprtje, prebavne težave, izguba apetita,
Dry mouth, constipation, indigestion, pain/discomfort in the belly (abdomen), retching, dry heaving, bright red blood in the stool
uha usta, zaprtost, prebavne motnje, bolečine/neprijeten občutek v trebuhu, siljenje na bruhanje, sprožanje refleksa bruhanja, svetlo rdeča kri v blatu
Dry mouth, constipation, vomiting, flatulence, diarrhoea, nausea, swollen abdomen
uha usta, zaprtje, bruhanje, napenjanje, diareja, slabost s siljenjem na bruhanje, napihnjenost trebuha
Dry mouth, constipation, vomiting, flatulence, diarrhoea, nausea, swollen abdomen
uha usta, zaprtje, bruhanje, napenjanje, driska, slabost s siljenjem na bruhanje, napihnjenost trebuha
Dry mouth, constipation, vomiting, flatulence, diarrhoea, nausea, swollen abdomen.
Suha usta, zaprtje, bruhanje, napenjanje, driska, slabost s siljenjem na bruhanje, napihnjenost trebuha.
Dry mouth, constipation, vomiting, flatulence, diarrhoea, nausea, swollen abdomen.
uha usta, zaprtje, bruhanje, napenjanje, driska, slabost s siljenjem na bruhanje, napihnjenost trebuha
Dry mouth, constipation.
Suha usta, zapeka.
Dry mouth, difficulty in swallowing
uha usta, oteženo požiranje
dry mouth, difficulty or painful swallowing, inflammation of the gullet (oesophagitis)
uha usta, težavno ali boleče požiranje, vnetje požiralnika (oesophagitis);
Dry mouth, dry skin or dry eye.
uha usta, suha koža ali suhe oči,
Dry mouth, Dyspepsia
uha usta, dispepsija
Dry mouth, flatulence (excessive amount of air or gases in the stomach or the intestine), stomach ache
uha usta, vetrovi (čezmerna količina zraka ali plinov v želodcu ali črevesu), bolečina v želodcu;
dry mouth, headache
uha usta, glavobol
dry mouth, headache.
uha usta, glavobol.
dry mouth, mouth inflammation, retching, constipation, distension of the abdomen, inflammation of the pancreas, vomiting blood, decrease of appetite;
uha usta, vnetje v ustih, siljenje na bruhanje ali bruhanje, zaprtje, napihnjenost trebuha, vnetje trebušne slinavke, bruhanje krvi, zmanjšan tek
Dry mouth, nausea, retching
suha usta, navzea, spahovanje
dry mouth, numbness around the mouth sweating, generalised redness of the skin, joint pains, pains in muscles and bones
uha usta, otrplost okoli ust, potenje, splošna pordelost kože, bolečine v sklepih, mišicah in kosteh.
dry mouth, sore throat, mouth sores
uha usta, vneto grlo oziroma žrelo, rane v ustni votlini
dry mouth, sore throat, mouth sores
uha usta, vneto žrelo oziroma grlo, rane v ustni votlini
dry mouth, strange taste in your mouth or difficulty swallowing
uha usta, nenavaden okus v ustih ali težave s požiranjem;
dry mouth, strange taste in your mouth or difficulty swallowing
uha usta, čuden okus v ustih ali težave pri požiranju,
dry mouth, strange taste in your mouth or difficulty swallowing
uha usta, čuden okus v ustih, težave pri požiranju,
Dry mouth.
uha usta,
Dry mouth.
uhost ust
dry mouth; indigestion (dyspepsia); rectal bleeding (rectal haemorrhage); lip inflammation (cheilitis); heartburn (gastroesophageal reflux);
uhost ust, prebavne motnje (dispepsija), krvavitev iz danke (rektalna krvavitev), vnetje ustnic (heilitis), zgaga (gastroezofagealni refluks),
dry or painful eyes
uhe ali boleče oči,
Dry powder: 3 years After reconstitution:
Suhi prašek: 3 leta Po rekonstituciji
Dry skin
bolečina v vratu
Dry skin
uha koža
dry skin
uha koža,
Dry skin
uha koža;
Dry skin ; Desquamation
suha koža , luščenje
Dry skin ; Desquamation
suha koža, luščenje
dry skin paleness (rare after booster)
uha koža bledica (po poživitvenem odmerku je redka)
dry skin, eyelid margin crusting, pruritus
suha koža, tvorba krast na robovih vek, pruritus
dry skin, flaking and inflammation of the skin, change in skin colour, loss of body weight.
uho kožo, luskavost in vnetje kože, spremembo barve kože, hujšanje.
Dry skin, itching (pruritus)
uha koža, srbenje (pruritus)
Dry skin, nail disorders, mild alopecia, acne, erythema, onychoclasis, palmar-plantar erythrodysaesthesia syndrome, skin exfoliation, skin lesion
uha koža, bolezni nohtov, blaga alopecija, akne, rdečina, lomljenje nohtov, palmo-plantarna eritrodisestezija (sindrom dlani in stopal), luščenje kože, kožne spremembe
Dry skin, pruritus
inkontinenca seča
Dry skin, pruritus
stomatitis, driska, dispepsija, disfagija, suha usta
Dry skin, pruritus
suha koža, srbenje
dry skin, rash, itchy rash
uha koža, izpuščaj, srbeč izpuščaj
dry skin, redness of the skin
uha koža, pordela koža,
Dry skin, Skin discoloration
uha koža, obarvanje kože
Dry skin, skin discolouration
uha koža, obarvanje kože
Dry skin, skin discolouration, pigmentation abnormal, erythema
uha koža, obarvanje kože, nenormalna pigmentacija kože, eritem
Dry skin, skin exfoliation, skin lesions
uha koža, luščenje kože, kožne spremembe
dry skin, thickening and itching of the skin
uha koža, zadebelitev in srbenje kože,
dry skin, unusual hair loss or thinning, rash, itching
uha koža, neobičajno izpadanje ali redčenje las, izpuščaj, srbenje
Dry skin.
uha koža,
Dry skin;
suha koža, luščenje
dry skin;
uha koža
Dry skin; Desquamation
suha koţa, luščenje
Dry skinf
uha kožaf
Dry socket (inflammation and pain after a tooth extraction)
indrom suhe jamice (vnetje in bolečina po izdrtju zoba)
Dry throat
suho grlo
dry throat
uho grlo,
Dry throat
uho žrelo
dry throat, disturbance in taste hives (itchy rash), feeling thirsty Reporting of side effects
uho grlo, motnje v okušanju koprivnica (srbeč izpuščaj), občutek žeje Poročanje o neželenih učinkih
Dry, itchy or acne like skin
uha, srbeča ali aknasta koža
Dry, red or itchy eyes
uhe, pordele in srbeče oči
dry, sore, or inflamed mouth, odd taste sensation
uha, boleča ali vneta usta, občutek čudnega okusa,
drying out which may be due to diarrhoea or reduced fluid intake
izguba tekočine, ki je lahko posledica driske ali zmanjšanega vnosa tekočine
Drying-out of the body (dehydration)
izguba vode iz telesa (dehidracija)
Drynam Road, Swords, Co. Dublin,
Drynam Road, Swords Co.
Dryness
uhe oči,
Dryness in the nose, congestion in the chest, cough
uhost nosne sluznice, nabiranje sluzi v pljučih, kašelj
dryness of the eye
uhe oči,
Dryness of the skin
uha koža
DSGA b, clear or almost clear
DSGA b, čisto ali skoraj čisto
DTG 50 mg BID N=88*
DTG 50 mg dvakrat na dan N=88
DTG 50 mg once daily
DTG 50 mg enkrat dnevno
DTG 50 mg once daily
DTG 50 mg enkrat na dan
DTPa HBV IPV for Infanrix hexa Suspension for suspension for injection I.M.
DTPa HBV IPV za Infanrix hexa Suspenzija za suspenzijo za injiciranje i.m.
DTPw HBV for Quintanrix I.M.
DTPw HBV za Quintanrix i.m.
Duaklir Genuair 340 micrograms /12 micrograms inhalation powder aclidinium/formoterol fumarate dihydrate
Duaklir Genuair 340 mikrogramov/12 mikrogramov prašek za inhaliranje aklidinij/formoterolijev fumarat dihidrat
Duaklir Genuair 340/12 mcg inhalation powder Aclidinium/Formoterol fumarate dihydrate
Duaklir Genuair 340/12 μg prašek za inhaliranje aklidinij/formoterolijev fumarat dihidrat
Duaklir Genuair 340/12 micrograms inhalation powder Aclidinium/Formoterol fumarate dihydrate
Duaklir Genuair 340/12 mikrogramov prašek za inhaliranje aklidinij/formoterolijev fumarat dihidrat
Duaklir Genuair Duaklir Genuair Duaklir Genuair
Duaklir Genuair 340
Duaklir Genuair improved daily symptoms of COPD such as ‘breathlessness’, ‘chest symptoms’, ‘cough and sputum’ (assessed by E-RS total score) as well as overall night-time symptoms, overall early morning symptoms and symptoms limiting early morning activities compared to placebo, aclidinium and formoterol but the improvements were not always statistically significant.
Zdravilo Duaklir Genuair je v primerjavi s placebom, aklidinijem in formoterolom (vsi p < 0,05) izboljšalo tudi dnevne simptome KOPB, kot so »zasoplost«, »simptomi v prsnem košu«, »kašelj in sputum«, (ocenjene na osnovi celokupne ocene E-RS) ter nočne in zgodnje jutranje simptome ter simptome, ki bolnika omejujejo pri zgodnjih jutranjih aktivnostih, vendar izboljšanja niso bila vedno statistično značilna.
Duaklir Genuair is a white or almost white powder.
Zdravilo Duaklir Genuair je bel ali skoraj bel prašek.
Duaklir Genuair is not for use in children or adolescents below 18 years of age.
Zdravilo Duaklir Genuair ni namenjeno za otroke ali mladostnike do 18. leta starosti.
Duaklir Genuair is unlikely to affect your ability to drive or use machines.
Malo verjetno je, da bi zdravilo Duaklir Genuair vplivalo na vašo sposobnost upravljanja vozil in strojev.
Dual blockade of RAAS through the combined use of ACE inhibitors, ARBs or aliskiren is therefore not recommended (see sections 4.5 and 5.1).
Dvojna blokada sistema RAAS s hkratno uporabo zaviralcev ACE, antagonistov angiotenzinskih receptorjev ali aliskirena zato ni priporočljiva (glejte poglavji 4.5 in 5.1).
Dual blockade of the RAAS with aliskiren, ARBs or ACEIs
Dvojno zaviranje sistema renin-angiotenzin-aldosteron s aliskirenom, antagonistev receptorjev angiotenzina II in zaviralcev ACE
Dual blockade of the RAAS with aliskiren, ARBs or ACEIs
Dvojno zaviranje sistema renin-angiotenzin-aldosteron z aliskirenom, antagonistov receptorjev angiotenzina II in zaviralcev ACE
Dual blockade of the RAAS with ARBs, ACE inhibitors or aliskiren
Dvojno zaviranje sistema renin-angiotenzin-aldosteron z antagonisti angiotenzinskih receptorjev, zaviralci ACE ali aliskirenom
Dual blockade of the renin-angiotensin-aldosterone system
Dvojno zaviranje renin-angiotenzin-aldosteronskega sistema
Dual blockade of the renin-angiotensin-aldosterone system (RAAS)
Dvojno zaviranje renin-angiotenzin-aldosteronskega sistema (RAAS)
Dual blockade of the renin-angiotensin-aldosterone system (RAAS):
Dvojna blokada sistema renin-angiotenzin-aldosteron (RAAS):
Dual Chamber Cartridge (DCC) composed of a Type 1 glass barrel sealed with bromobutyl rubber stoppers and a bromobutyl rubber closure disc encased in a polypropylene snap on cap.
Vložek z dvema razdelkoma (DCC – Dual Chamber Cartridge), ki ga sestavlja valj iz stekla tipa I, zaprt z zamaški iz brombutilne gume in zapornim diskom iz brombutilne gume, vloženim v polipropilensko zaskočno zaporko.
Dual Chamber Cartridge (DCC) in pre-filled pen
Vložek z dvema razdelkoma (DCC – Dual Chamber Cartridge), vstavljen v napolnjen peresnik
Dual RAAS blockade
Dvojno zaviranje RAAS
Dual therapies containing Victoza (0.6 mg, 1.2 mg or 1.8 mg) and metformin or a sulphonylurea led to reductions in HbA1c of around 1 percentage point compared with no reduction without Victoza.
Zdravljenje z dvema zdraviloma, ki je vključevalo kombinacijo zdravila Victoza (0,6 mg, 1,2 mg ali 1,8 mg) in metformina ali sulfonilsečnine, je zmanjšalo ravni HbA1c za približno 1 odstotno točko, medtem ko pri zdravljenju, ki ni vključevalo zdravila Victoza, zmanjšanja ni bilo.
Dual therapy with metformin (26 weeks)
Dvotirno zdravljenje z metforminom (26 tednov)
Dual therapy with metformin (26 weeks)
Dvotirno zdravljenje z metforminom (26 weeks)
DUAVIVE 0.45 mg/20 mg modified-release tablets Conjugated oestrogens/bazedoxifene
DUAVIVE 0,45 mg/20 mg tablete s prirejenim sproščanjem konjugirani estrogeni/bazedoksifen
DUAVIVE contains bazedoxifene, which reduces the risk of endometrial hyperplasia that can occur with oestrogen-only use (see section 4.4).
Zdravilo DUAVIVE vsebuje bazedoksifen, ki zmanjša tveganje za hiperplazijo endometrija, ki se lahko pojavi pri uporabi samostojnega estrogena (glejte poglavje 4.4).
DUAVIVE contains lactose, sucrose, glucose (in polydextrose and maltitol liquid) and sorbitol (in polydextrose).
Zdravilo DUAVIVE vsebuje laktozo, saharozo, glukozo (v obliki polidekstroze in tekočega maltitola) in sorbitol (v obliki polidekstroze).
DUAVIVE contains lactose, sucrose, polydextrose and maltitol liquid
Zdravilo DUAVIVE vsebuje laktozo, saharozo, polidekstrozo in tekoči maltitol
DUAVIVE has a minor influence on the ability to drive and use machines.
Zdravilo DUAVIVE ima blag vpliv na sposobnost vožnje in upravljanja s stroji.
DUAVIVE has no known effect on the ability to drive or use machines.
Zdravilo DUAVIVE nima znanega vpliva na sposobnost vožnje in upravljanja s stroji.
DUAVIVE has not been studied in the treatment of premature menopause.
Zdravljenja prezgodnje menopavze z zdravilom DUAVIVE niso raziskovali.
DUAVIVE has not been studied in women over 75 years of age.
Zdravila DUAVIVE niso raziskovali pri ženskah, starejših od 75 let.
DUAVIVE is a medicine that contains two active substances called conjugated oestrogens and bazedoxifene.
DUAVIVE je zdravilo, ki vsebuje dve zdravilni učinkovini, imenovani konjugirani estrogeni in bazedoksifen.
DUAVIVE is contraindicated during breast-feeding (see section 4.3).
Zdravilo DUAVIVE je med dojenjem kontraindicirano (glejte poglavje 4.3).
DUAVIVE is contraindicated in these patients (see section 4.3).
Zdravilo DUAVIVE je zato pri teh bolnicah kontraindicirano (glejte poglavje 4.3).
DUAVIVE is indicated for:
Zdravilo DUAVIVE je indicirano za:
DUAVIVE is only for use in postmenopausal women, and is contraindicated in women who are or may become pregnant (see section 4.3).
Zdravilo DUAVIVE je namenjeno le za uporabo pri ženskah v postmenopavzi in je kontraindicirano pri nosečnicah ali ženskah v rodni dobi (glejte poglavje 4.3).
DUAVIVE is only indicated for use in postmenopausal women and must not be taken by women of childbearing potential (see sections 4.6 and 5.3).
Zdravilo DUAVIVE je indicirano za uporabo samo pri ženskah v postmenopavzi in ga ženske v rodni dobi ne smejo jemati (glejte poglavji 4.6 in 5.3).
DUAVIVE is used for: Relief of symptoms occurring after menopause
Zdravilo DUAVIVE se uporablja za: Lajšanje simptomov, ki se pojavijo po menopavzi
DUAVIVE is used in postmenopausal women who still have their uterus (womb) with at least 12 months since their last natural period.
Zdravilo DUAVIVE se uporablja pri ženskah po menopavzi, ki imajo še vedno maternico in pri katerih je minilo najmanj 12 mesecev od zadnjega naravnega mesečnega perila.
DUAVIVE may be taken at any time of day, without regard to meals (see section 5.2).
Zdravilo DUAVIVE se lahko jemlje kadarkoli čez dan, ne glede na obroke (glejte poglavje 5.2).
DUAVIVE may increase the risk of blood clots.
Zdravilo DUAVIVE lahko zveča tveganje za krvne strdke.
DUAVIVE pairs CE with the selective oestrogen receptor modulator (SERM), bazedoxifene, which is defined as a tissue selective oestrogen complex (TSEC).
Zdravilo DUAVIVE vsebuje CE in selektivni modulator estrogenskih receptorjev (SERM – selective oestrogen receptor modulator) bazedoksifen, kar je opredeljeno kot tkivno selektivni estrogenski kompleks (TSEC – tissue selective oestrogen complex).
DUAVIVE with drink
Zdravilo DUAVIVE skupaj s pijačo
Ducks:
Race:
Due date
Datum izpolnitve zaveze
Due Date
Do datuma
Due date
Izvesti do
Due date
Posodobitev
Due Date
Rok
Due Date
Rok izvedbe
Due date
Tímamörk
Due dates
Roki
Due to a difference in the bioavailability of emtricitabine between the hard capsule and oral solution presentations, 240 mg emtricitabine administered as the oral solution (24 ml) should provide similar plasma levels to those observed after administration of one 200 mg emtricitabine hard capsule (see section 5.2).
Zaradi razlike v biološki uporabnosti emtricitabina, uporabljenega v obliki trde kapsule ali v obliki peroralne raztopine, naj bi 240 mg emtricitabina, uporabljenega v obliki peroralne raztopine (24 ml), zagotavljalo podoben plazemski nivo, kot je opazen po uporabi emtricitabina v obliki ene 200 mg trde kapsule (glejte poglavje 5.2).
Due to a lack of proper toxicokinetic data, comparison to human clinical exposure was not possible.
Ker ustreznih toksikokinetičnih podatkov ni na voljo, primerjava s klinično izpostavljenostjo pri ljudeh ni bila možna.
Due to a lower bioavailability of the daily dose of Plenadren compared to that of conventional hydrocortisone tablets given three times daily (see section 5.2) clinical response needs to be monitored and further dose individualisation may be required.
Zaradi nižje biološke razpoložljivosti dnevnega odmerka zdravila Plenadren v primerjavi s konvencionalnimi tabletami hidrokortizona, ki se jemljejo trikrat na dan (glejte poglavje 5.2), je treba spremljati klinični odziv in po potrebi dodatno prilagoditi odmerke.
Due to a potential increase in tractional forces, there is a risk of occurrence of new or enlarged macular holes.
Zaradi možnosti povečanja trakcijskih sil obstaja tveganje za nastanek novih ali povečanih foramnov makule.
Due to age-differences in plasma protein binding, the corresponding increase in free sildenafil plasma concentration was approximately 40 %.
Zaradi starostnih razlik v vezavi na beljakovine v plazmi so se ustrezne plazemske koncentracije prostega sildenafila povečale za približno 40 %.
Due to age-differences in plasma protein binding, the corresponding increase in free sildenafil plasma concentration was approximately 40 %.
Zaradi starostno pogojenih razlik v vezavi na beljakovine v plazmi so se plazemske koncentracije prostega sildenafila ustrezno zvečale za približno 40 %.
Due to age-differences in plasma protein binding, the corresponding increase in free sildenafil plasma concentration was approximately 40%.
Zaradi starostnih razlik v vezavi na beljakovine se je koncentracija prostega sildenafila v plazmi povečala za približno 40%.
Due to age-differences in plasma protein binding, the corresponding increase in free sildenafil plasma concentration was approximately 40%.
Zaradi starostno pogojenih razlik v vezavi na beljakovine v plazmi so se plazemske koncentracije prostega sildenafila ustrezno povečale za približno 40 %.
Due to an increase in the unbound darunavir plasma concentrations, PREZISTA should be used with caution in patients with mild or moderate hepatic impairment (see sections 4.2, 4.3 and 5.2).
Zaradi zvišanja plazemske koncentracije nevezanega darunavirja, je treba pri bolnikih z blago do zmerno okvaro jeter zdravilo PREZISTA uporabljati previdno (glejte poglavja 4.2, 4.3 in 5.2).
Due to an increased bleeding risk, concomitant treatment with any other anticoagulants is contraindicated (see section 4.3).
Zaradi povečanega tveganja za krvavitve je sočasno zdravljenje s katerimkoli drugim antikoagulantom kontraindicirano (glejte poglavje 4.3).
Due to an increased bleeding risk, concomitant treatment with any other anticoagulants is contraindicated (see section 4.3).
Zaradi povečanega tveganja za pojav krvavitev je sočasno zdravljenje s katerimkoli drugim antikoagulantom kontraindicirano (glejte poglavje 4.3).
Due to an increased risk of fever, tenderness at the injection site, change in eating habits and irritability when Bexsero was co-administered with the above vaccines, separate vaccinations can be considered when possible.
Zaradi povečanega tveganja za pojav zvišane telesne temperature, občutljivosti na mestu injiciranja, spremembe prehranjevalnih navad in razdražljivosti pri sočasnem dajanju cepiva Bexsero z zgoraj navedenimi cepivi, je, kadar je mogoče, potrebno razmisliti o ločenem cepljenju.
Due to an increased risk of infection, patients taking Simponi must be monitored closely for infections, including tuberculosis, during and for up to five months after treatment.
Zaradi povečanega tveganja za okužbo je treba bolnike, ki prejemajo zdravilo Simponi, med zdravljenjem in do pet mesecev po njegovem zaključku skrbno opazovati zaradi morebitnih okužb, ki vključujejo tudi tuberkulozo.
Due to both the potential risk of neonate hypoglycaemia related to metformin and the lack of human data with vildagliptin, Eucreas should not be used during breast-feeding (see section 4.3).
Tako zaradi potencialnega tveganja, da bi pri novorojenčku zaradi metformina prišlo do hipoglikemije, kot tudi zaradi pomanjkanja podatkov o vildagliptinu pri ljudeh, se zdravila Eucreas ne sme uporabljati v obdobju dojenja (glejte poglavje 4.3).
Due to both the potential risk of neonate hypoglycaemia related to metformin and the lack of human data with vildagliptin, Icandra should not be used during breast-feeding (see section 4.3).
Tako zaradi potencialnega tveganja, da bi pri novorojenčku zaradi metformina prišlo do hipoglikemije, kot tudi zaradi pomanjkanja podatkov o vildagliptinu pri ljudeh, se zdravila Icandra ne sme uporabljati v obdobju dojenja (glejte poglavje 4.3).
Due to both the potential risk of neonate hypoglycaemia related to metformin and the lack of human data with vildagliptin, Zomarist should not be used during breast-feeding (see section 4.3).
Tako zaradi potencialnega tveganja, da bi pri novorojenčku zaradi metformina prišlo do hipoglikemije, kot tudi zaradi pomanjkanja podatkov o vildagliptinu pri ljudeh, se zdravila Zomarist ne sme uporabljati v obdobju dojenja (glejte poglavje 4.3).
Due to canagliflozin’s mechanism of action, patients taking Vokanamet will test positive for glucose in their urine.
Pri bolnikih, ki jemljejo zdravilo Vokanamet, je zaradi mehanizma delovanja kanagliflozina, rezultat testa prisotnosti glukoze v urinu pozitiven.
Due to catumaxomab’s binding properties, tumour cells, T-cells and accessory immune cells come in close proximity.
Zaradi katumaksomabove sposobnosti vezave se celice tumorja, T-celice in dodatne imunske celice zelo približajo.
Due to CYP3A and P-gp
Zaradi inhibicije CYP3A in P-gp
Due to CYP3A and P-gp
zaradi zavrtja CYP3A z
Due to CYP3A and P-gp inhibition by lopinavir/ritonavir.
lopinavir/ritonavir z inhibicijo
due to CYP3A induction by
ugotovi, ali je potrebno odmerek
Due to CYP3A inhibition by
4-krat na dan
due to CYP3A inhibition by
AUC: ↑ 11-krat zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem.
Due to CYP3A inhibition by
Zaradi pričakovane povečane
due to CYP3A inhibition by
Zaradi zavrtja CYP3A z
Due to CYP3A inhibition by
Zaradi zavrtja CYP3A z lopinavirjem/ritonavirjem.
Due to CYP3A inhibition by darunavir, concentrations of the antipsychotics/neuroleptics are expected to increase.
Darunavir zavira CYP3A, zato je pričakovati zvišanje koncentracije antipsihotikov/nevroleptikov.
Due to CYP3A inhibition by Kaletra
AUC: ↑ 4-krat zaradi zavrtja CYP3A z zdravilom Kaletra.